Exagen Inc. (XGN)

NASDAQ: XGN · IEX Real-Time Price · USD
9.10
0.35 (4.00%)
Jan 26, 2022 4:00 PM EST - Market closed

Total Valuation

Exagen has a market cap or net worth of $147.09 million. The enterprise value is $67.62 million.

Market Cap147.09M
Enterprise Value67.62M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Exagen has 16.16 million shares outstanding. The number of shares has increased by 34.02% in one year.

Shares Outstanding16.16M
Shares Change (YoY)+34.02%
Shares Change (QoQ)+0.10%
Owned by Insiders (%)22.73%
Owned by Institutions (%)79.68%
Float6.27M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio3.05
PB Ratio1.62
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales1.40
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 14.62, with a Debt / Equity ratio of 0.30.

Current Ratio14.62
Quick Ratio14.33
Debt / Equity0.30
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -28.10%, which is considered low. The company has a ROIC of -61.00%.

Return on Equity (ROE)-28.10%
Return on Assets (ROA)-19.50%
Return on Capital (ROIC)-61.00%
Revenue Per Employee$266,729
Profits Per Employee-$128,459
Employee Count181
Asset Turnover0.41
Inventory Turnovern/a

Taxes

In the past 12 months, Exagen has paid $39,000 in taxes.

Income Tax39,000
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -42.30% in the last 52 weeks. The beta is 0.50, so Exagen's price volatility has been lower than the market average.

Beta (1Y)0.50
52-Week Price Change-42.30%
50-Day Moving Average10.15
200-Day Moving Average12.07
Average Volume (30 Days)38,968

Short Selling Information

Short Interest66,710
Short % of Shares Out0.41%
Short % of Float1.06%
Short Ratio (days to cover)1.50

Income Statement

In the last 12 months, Exagen had revenue of $48.28 million and -23.25 million in losses. Earnings per share was -$1.56.

Revenue48.28M
Gross Profit28.29M
Operating Income-20.57M
Pretax Income-23.21M
Net Income-23.25M
EBITDA-19.76M
EBIT-20.57M
Earnings Per Share (EPS)-$1.56
Full Income Statement

Balance Sheet

The company has $106.77 million in cash and $27.29 million in debt, giving a net cash position of $79.48 million or $4.92 per share.

Cash & Cash Equivalents106.77M
Total Debt27.29M
Net Cash79.48M
Net Cash Per Share$4.92
Book Value90.80M
Book Value Per Share5.62
Working Capital110.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.12 million and capital expenditures -$1.31 million, giving a free cash flow of -$19.43 million.

Operating Cash Flow-18.12M
Capital Expenditures-1.31M
Free Cash Flow-19.43M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 58.61%, with operating and profit margins of -42.62% and -48.16%.

Gross Margin58.61%
Operating Margin-42.62%
Pretax Margin-48.08%
Profit Margin-48.16%
EBITDA Margin-40.94%
EBIT Margin-42.62%
FCF Margin-40.25%

Dividends & Yields

Exagen does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-15.81%
FCF Yield-13.21%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a